These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Complement Therapeutics in Autoimmune Disease. Thurman JM; Yapa R Front Immunol; 2019; 10():672. PubMed ID: 31001274 [TBL] [Abstract][Full Text] [Related]
11. Complement in the Homeostatic and Ischemic Brain. Alawieh A; Elvington A; Tomlinson S Front Immunol; 2015; 6():417. PubMed ID: 26322048 [TBL] [Abstract][Full Text] [Related]
12. CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation. Holers VM; Rohrer B; Tomlinson S Adv Exp Med Biol; 2013; 735():137-54. PubMed ID: 23402024 [TBL] [Abstract][Full Text] [Related]
13. Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics. Melis JP; Strumane K; Ruuls SR; Beurskens FJ; Schuurman J; Parren PW Mol Immunol; 2015 Oct; 67(2 Pt A):117-30. PubMed ID: 25697848 [TBL] [Abstract][Full Text] [Related]
14. Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement. Alawieh A; Elvington A; Zhu H; Yu J; Kindy MS; Atkinson C; Tomlinson S J Neuroinflammation; 2015 Dec; 12():247. PubMed ID: 26714866 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease. de Boer ECW; van Mourik AG; Jongerius I Front Immunol; 2020; 11():578069. PubMed ID: 33362763 [TBL] [Abstract][Full Text] [Related]